Skip to main content

Full Schedule

Full Schedule

  • Wednesday, September 16, 2026
  • 6:30 AM - 5:30 PM EDT
    Registration Hours
  • 6:30 AM - 5:30 PM EDT
    Speaker Ready Room Hours
  • 7:00 AM - 8:00 AM EDT
    Community Gathering (Continental Breakfast)
  • 8:00 AM - 9:00 AM EDT
    Morning Plenary Session
  • 9:15 AM - 10:15 AM EDT
    Advancing Representation in Clinical Trials: Scientific and Operational Strategies for Population-Reflective Enrollment
  • 9:15 AM - 10:30 AM EDT
    Back by Popular Demand: The Evolution of U.S. and EU Regulatory Policies and Excellence
  • 9:15 AM - 10:30 AM EDT
    Biomarker‑Based Endpoints in Drug Development: Scientific Rigor and Regulatory Perspectives
  • 9:15 AM - 10:30 AM EDT
    Diverse Women in Regulatory Affairs: Leadership and Career Pathways
  • 9:15 AM - 10:30 AM EDT
    New Session Topic: Accelerated Drug Development
  • 9:15 AM - 10:30 AM EDT
    New Session Topic: IVDR Revision Proposal
  • 9:15 AM - 10:30 AM EDT
    Small Manufacturers Challenges and Lessons Learned
  • 10:30 AM - 11:00 AM EDT
    Networking Refreshment Break in Exhibit Hall
  • 10:30 AM - 1:00 PM EDT
    Exclusive Exhibit Hall Hours: Networking & Presentations
  • 10:30 AM - 4:30 PM EDT
    Exhibit Hall Hours
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: Including Regulatory Requirements in Partnership Agreements for Joint Drug and Combination Product Development
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: Maximizing the Potential of Meetings with the FDA
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: QMSR Transition: What Gaps Are Manufacturers Underestimating and How to Prioritize Remediation
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: FDA Pre-Submission Strategy: How to Plan, Execute, and Maximize Regulatory Feedback
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: The Invisible Dossier: Networking as a Regulatory Requirement
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: When is the Same Moiety Different? The Clinical Superiority Provisions of FDA's Orphan Drug Regulations
  • 11:30 AM - 1:00 PM EDT
    Networking Lunch in Exhibit Hall
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: Breakthrough Designation: Is It Right for Your Device?
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: The US Reimbursement Landscape: Understanding Shifts and Changes in the Drug Pricing Narrative
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: The Volunteer Sandbox: Accelerating Regulatory Leadership through RAPS
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: From Access to Insight: A Call for Transparency and Disclosure
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Reg Ops to Reg Strategy and Everything In-Between: How to Become a Well-Rounded RA Professional
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Submission Strategies for Medical Devices in Brazil - Submission Pathways & Ongoing Challenges
  • 1:00 PM - 2:00 PM EDT
    Animal Health Drugs: The Approval & Lifecyle Process
  • 1:00 PM - 2:00 PM EDT
    Clinical Data Transferability: Strategies for Utilizing Cross-Regional Evidence in Regulatory Submissions
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: China Device Updates
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: CMC
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: MDR/IVDR State of Play
  • 1:00 PM - 2:00 PM EDT
    Regulatory Mentoring in the Workplace
  • 2:15 PM - 3:15 PM EDT
    Financial Literacy for Regulatory Affairs
  • 2:15 PM - 3:15 PM EDT
    Impact of AI on Regulatory Workforce.
  • 2:15 PM - 3:15 PM EDT
    In-Silico Trials - Global Perspectives and Solutions
  • 2:15 PM - 3:15 PM EDT
    Leveraging External Controls to Advance Global Regulatory Decision-Making
  • 2:15 PM - 3:15 PM EDT
    New Approach Methodologies (NAMs) in Preclinical Drug Development: Discussion of the Current Global Regulatory Landscape
  • 2:15 PM - 3:15 PM EDT
    New Session Topic: Direct to Consumer
  • 2:15 PM - 3:15 PM EDT
    New Session Topic: MDR Transition
  • 2:15 PM - 3:15 PM EDT
    Sticky Wickets in Statutory Authority: CDER’s Workarounds, Remote Participation, and the Legal Limits of FDA Inspection Power
  • 3:15 PM - 3:45 PM EDT
    Networking Refreshment Break in Exhibit Hall
  • 3:15 PM - 4:30 PM EDT
    Exclusive Exhibit Hall Hours: Networking & Presentations
  • 4:00 PM - 4:30 PM EDT
    Solutions Circle: How to 10x Productivity as a Regulatory Affairs Professional using AI
  • 4:00 PM - 4:30 PM EDT
    Solutions Circle: Navigating Social Media in Pharmacovigilance: Regulatory Uncertainty, Data Challenges, and Strategic Considerations for RA Professionals
  • 4:00 PM - 4:30 PM EDT
    Solutions Circle: Risk Assessment: Common Failures in Identification and Implementation of ISO 14971 as Seen by NBs
  • 4:30 PM - 5:30 PM EDT
    FemTech and Beyond: Addressing Sex-Based Disparities in Medical Devices and Pharmaceuticals
  • 4:30 PM - 5:30 PM EDT
    Global Biosimilarity Assessments: Key Regulatory Changes Impacting Biosimilar Development Strategy
  • 4:30 PM - 5:30 PM EDT
    ICH M4Q(R2) as the Inflection Point: Digitizing CMC Submissions and Operationalizing Responsible AI/ML
  • 4:30 PM - 5:30 PM EDT
    Navigating Global eIFU Excellence: Leveraging US and EU Best Practices for Strategic Implementation
  • 4:30 PM - 5:30 PM EDT
    New Session Topic: EUDAMED
  • 4:30 PM - 5:30 PM EDT
    The Convergence of Regulatory and Politics: A Closer Look at Congressional Proposals to Reform FDA
  • 5:45 PM - 7:15 PM EDT
    Honoring Excellence: RAPS 2026 Awards Celebration (Invitation Only)
  • 7:30 PM - 10:00 PM EDT
    Convergence Networking Party (Offsite Event, Location to Be Announced Soon)